HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 1,105-1,116 of 1,811
Behavioral study icon
CompletedNCT06365346

Music Breathing Therapy for Children With Attention-deficit Hyperactivity Disorder and Their Caregivers

Official study title

Dyadic Video-assisted Gamified Group-based Music Breathing Therapy on Enhancing Resilience Among Children With Attention-deficit Hyperactivity Disorder and Their Caregivers: A Pilot Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Hong Kong
ADHDBehavioural studyAges 7–12
Countries
China
Sponsor
Chinese University of Hong Kong
Drug study icon
CompletedNCT00586573

Study of Namenda in Adult Subjects With ADHD and ADHD NOS

What is this study about?

Researchers studied memantine hydrochloride to find out how it affected ADHD symptoms in adults with ADHD.

This study has finished and is no longer accepting participants.

In Cambridge
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT01416064

Extension Study to 810P202

What is this study about?

This study evaluated the safety of Molindone for people with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Dothan
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
Behavioral study icon
CompletedNCT05333887

Study of the Parental Friendship Coaching+ Program for Families of Children With Attention-deficit/Hyperactivity Disorder

Official study title

Moderators and Mediators of Behavioural Parent Training Outcomes for Children With Attention-deficit/Hyperactivity Disorder: Evaluating the Importance of Addressing Parent Psychopathology and Treatment Process Factors

This study has finished and is no longer accepting participants.

In Vancouver
ADHD, DepressionBehavioural studyAges 6+
Countries
Canada
Sponsor
University of British Columbia
Drug study icon
CompletedNCT00254878

Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14

Official study title

A 7 Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Cross-Over Evaluation of the Efficacy and Safety of Two Different Brands of Modified-Release Oral Dosage Forms of Methylphenidate-HCl (20 mg, q.d.) in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14

This study has finished and is no longer accepting participants.

In Freiburg im Breisgau
ADHDMedication studyAges 6–14
Countries
Germany
Sponsor
Novartis
Drug study icon
CompletedNCT00593112

Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate

Official study title

A Pilot Study of Proton Magnetic Spectroscopy in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) Before and After Treatment With Osmotic-controlled Release Oral Delivery System (OROS) Methylphenidate

This study has finished and is no longer accepting participants.

In Cambridge
ADHDMedication studyAges 12–18
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00763971

Safety study of Lisdexamfetamine Dimesylate (LDX) in ADHD

What is this study about?

Researchers compared Lisdexamfetamine Dimesylate (LDX), Methylphenidate Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in children and adolescents with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Hoboken
ADHDMedication studyAges 6–17
Countries
France, United Kingdom, Belgium, + 7 others
Sponsor
Shire

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.